Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 054339/0506 | |
| Pages: | 6 |
| | Recorded: | 11/11/2020 | | |
| Attorney Dkt #: | 020871-9121-US01 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/02/2021
|
Application #:
|
16086053
|
Filing Dt:
|
09/18/2018
|
|
Publication #:
|
|
Pub Dt:
|
06/11/2020
| | | | |
|
Title:
|
TREATMENT OF COGNITIVE AND MOOD SYMPTOMS IN NEURODEGENERATIVE AND NEUROPSYCHIATRIC DISORDERS WITH ALPHA5-CONTAINING GABAA RECEPTOR AGONISTS
|
|
|
Assignee
|
|
|
|
|
| 1440 EAST NORTH AVENUE |
| MILWAUKEE, WISCONSIN 53202 |
|
|
Correspondence name and address
|
| |
MICHAEL BEST & FRIEDRICH LLP
|
| |
790 N. WATER STREET
|
| |
SUITE 2500
|
| |
MILWAUKEE, WI 53202
|
Search Results as of:
06/23/2024 05:01 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
